Introduction
Morus nigra L. (M oraceae), known as "amoreira-preta" or "sarga-mora" in Brazil, is widely em ployed in folk medicine of many parts of the world as antiinflammatory, antiinfective, antidiabetic and for the treatm ent of other pathologies associated with dolorous processes (Graves, 1996; Michalak, 1997) .
Acetonic extract of root bark and callus ob tained from this plant revealed the presence of various flavonoids and Diels-Alder type adducts (Ferrari et al., 1999) . As part of our project to achieve naturally occurring analgesic substances, we selected several plants and evaluated their pos sible antinociceptive effects in mice. Among oth ers, M. nigra caused significative inhibition of ab dominal constrictions induced by acetic acid (unpublished results) . For this reason, we analysed whether morusin (1), the main prenylflavonoid of this plant, exhibits antinociceptive effects in mice. In addition, we compared its potency with some reference drugs, such as aspirin and paracetamol was deposited at Dipartimento di Biologia Vegetale, Universitä "La Sapienza", Rome, Italy [ROgeneral Herbarium].
Isolation o f morusin
Root barks (400 g) were extracted exhaustively with acetone (20.5 g). Part of the residue (10 g) was chromatographed on silica gel using a CHCl3:MeOH gradient as eluent. The crude com pounds obtained were submitted to further purifi cation either on silica gel (n-hexane: ethyl acetate) or LiChroprep. RP8 (M e0H :H 20 , 9:1 v/v), giving morusin (yield=3.5% of 400 g root barks). Spectral data were in accordance with those previously re ported (Nomura et al., 1981) .
Animals
Swiss mice of both sexes (25-35 g) were housed in automatically controlled temperature condi tions (23 ± 2 °C and 12 h light-dark cycles). The animals were given access to water and Nuvital chow ad libitum unless otherwise indicated. The animals remained in the appropriate laboratory of University of Itajaf Valey (UNIVALI) until some hours before of the experiments.
Pharmacological analysis

A bdom inal constriction response caused by intraperitoneal injection o f diluted acetic acid
The abdominal constriction induced by intraper itoneal injection of acetic acid (0 .6 %), was carried out according to the procedures described pre viously (Collier et al., 1968; Souza et al., 1998) with minor modifications. Animals were pretreated intraperitoneally (i.p.) with morusin (1) (23.8-142.9 mmol/kg) or standard drugs intraperitoneally 30 min before the acid acetic injection. Control an imals received a similar volume of 0.9% NaCl (10 ml/kg , i.p.). In a separate set of experiments, animals were pretreated either with compound 1 (23.8 mmol/kg, i.p.) or with morphine (13.3 mmol/ kg, subcutaneously, s.c.) 30 min before the acetic acid injection. We also analysed the effect of nalox one (3) (13.8 mmol/kg, i.p.) injected 10 min before hand, against the antinociceptive effect caused by both morphine and 1. After the challenge, each mouse was placed in a separate glass funnel and the number of abdominal contractions of the ab dominal muscles together with stretching, was cu mulatively counted over a period of 20 min. Anti nociceptive activity was expressed as the reduction of the number of abdominal contractions between control animals and mice pretreated with morusin and standard drugs.
Formalin-induced pain
The procedure used was essentially similar to that described previously ( 
Hot-plate test
The hot-plate was used to stimate the latency of responses according to the method described by Eddy and Leimback (1953) with minor modifica tions. The temperature of the hot-plate was main tained at 56 ± 3 °C. The animals («=10) were placed on glass funnels in the heated surface and the time between placing the animals and the be-ginning of licking paws or jumping were recorded as latency of response, in non-treated (saline 10 ml/kg, i.p) or morusin (23.8-142.9 mmol/kg, i.p.) animals.
Statistical analysis
The results are presented as mean ± s.e.m. and the statistical significance between groups was an alysed by means of the t test or analysis of variance followed by Dunnettös multiple comparison test, when appropriate. P values less than 0.05 were considered significant. The ID50 values (the dose of compound that reduced formalin-or acetic acid -induced pain by 50% relative to control val ues) were determined by graphical interpolation from individual experiments, which are accompa nied by their respective 95% confidence limits.
Results
The results shown in Fig. 1 with naloxone (13.8 mmol/kg, i.p.), a non-selective morphine receptor antagonist, 1 0 min before the noxious stimuli, morusin (142.9 mmol/kg, i.p.) re versed the antinociceptive effect when compared to morphine (Fig. 3) .
In the formalin test, 1 significantly inhibited (P <0,05) dose-dependently both the first and se cond phases by the systemic route (Fig. 4) . The cal culated ID50 ' s values for 1 th and 2 th phases were 67.1 (40.7-111.9) and 63.8 (38.7-106.7) mmol/kg for the systemic route, with maximum inhibitions (MI) of 6 6 .8 ± 2.4 and 81.0 ± 4%, respectively. The standard drugs dose-dependently prevented only the inflammatory effects (second phase), with ID50 of about 120 mmol/kg (Gaertner et al., 1999) . Morusin was ineffective in antagonizing the formalin-induced hindpaw oedema (results not shown).
In the hot-plate test, 1 ((23.8-142.9 mmol/kg, i.p.) was capable of increasing dose-dependently the latency period of pain induced by heating of the plate (Fig. 5) . was reported that 1 showed significant effects on arachidonic acid-, collagen-, and -platelet aggrega tion factor (PAF) assays ( Ko et al., 1997). In summary, our results demonstrate for the first time that morusin (1 ) exerts a marked antinoci ceptive effect by the systemic route, in distinct models of nociception in mice, consisting of the main active component of M. nigra. It was about 2 -fold more potent than some drugs clinically em ployed against dolorous processes.
Discussion
The mechanism by which the morusin exerts antinociceptive activity still remains undeter mined, but our results strongly suggest that it in volves the participation of the opioid system. Con sidering its promising pharmacological action and good yield from the plant, 1 might be further used as a model to obtain new more potent derivatives and/or selective analgesic drugs.
